CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.265
-0.025 (-1.10%)
At close: Apr 28, 2026, 4:00 PM EDT
2.310
+0.045 (2.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
CNS Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 6.21 | 5.61 | 4.77 | 5.97 | 4.68 | |
| Research & Development | 9.77 | 9.29 | 14.1 | 9.3 | 9.81 | |
| Operating Expenses | 15.99 | 14.9 | 18.87 | 15.27 | 14.49 | |
| Operating Income | -15.99 | -14.9 | -18.87 | -15.27 | -14.49 | |
| Interest Expense | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | |
| Interest & Investment Income | 0.15 | 0.06 | 0.03 | - | - | |
| Other Non Operating Income (Expenses) | -0 | - | - | - | - | |
| EBT Excluding Unusual Items | -15.85 | -14.86 | -18.85 | -15.27 | -14.5 | |
| Pretax Income | -15.85 | -14.86 | -18.85 | -15.27 | -14.5 | |
| Net Income | -15.85 | -14.86 | -18.85 | -15.27 | -14.5 | |
| Net Income to Common | -15.85 | -14.86 | -18.85 | -15.27 | -14.5 | |
| Shares Outstanding (Basic) | 0 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 0 | 0 | - | - | - | |
| Shares Change (YoY) | 1293.23% | - | - | - | - | |
| EPS (Basic) | -35.75 | -466.89 | - | - | - | |
| EPS (Diluted) | -35.75 | -466.89 | - | - | - | |
| Free Cash Flow | -13.83 | -17.12 | -14.14 | -10.56 | -13.54 | |
| Free Cash Flow Per Share | -31.19 | -537.90 | - | - | - | |
| EBITDA | -15.98 | -14.9 | -18.86 | -15.26 | -14.47 | |
| D&A For EBITDA | 0 | 0 | 0 | 0.01 | 0.01 | |
| EBIT | -15.99 | -14.9 | -18.87 | -15.27 | -14.49 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.